On 8–9 October 2026, we aligned the country-availability page with the catalog field used by Compare and the test finder, replaced stale test names with catalog names, and linked each listing to its Compare card. The UK now includes listed tests such as Muhdo. We removed a Thorne-specific restriction sentence from the US note because Thorne is no longer in the active catalog, and corrected the Canada note rather than presenting Elysium and GlycanAge as listed Canadian shipping options. The homepage replaced Strongest evidence and Best-in-class wording with Most studied, explicitly states the Promising tier for the featured clocks, and removed an uncited numerical study count. No evidence-tier assignments changed.
Separate country lists and stale logistics notes disagreed with the comparison catalog. Homepage labels could imply stronger evidence than the published methodology supports.
Readers see consistent listed availability across country pages, Compare and the finder, and less overstated evidence wording. These are catalog availability listings, not a guarantee of shipping, customs clearance or clinical suitability; check the vendor before ordering. Routine navigation and URL cleanup are not presented as scientific changes.
Affected entities
Primary
- site sectionProviders
Secondary
- site sectionHome
- compare pageCompare tests